$1B

SV Health Investors is a leading venture capital firm focused on investing in innovative healthcare companies. With a mission to transform healthcare one investment at a time, SV Health Investors supports diverse entrepreneurs in creating breakthrough companies and treatments. The firm has a strong track record of investing in companies that improve healthcare through innovative care delivery models, next-generation digital health technologies, and groundbreaking medical products. SV Health Investors is committed to diversity and believes that it strongly contributes to success.

Foresite Capital is a multi-stage healthcare and life sciences investment firm dedicated to addressing significant unmet needs by funding promising businesses at all stages of their life cycles. The firm employs a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare. Foresite Capital focuses on breakthrough opportunities at the intersection of technology and biotech, systematically identifying key undercurrents driving change.

Flare Capital Partners is a leading venture capital firm dedicated to transforming the healthcare industry by investing in innovative healthcare technology companies. The firm partners with exceptional founders to address significant market opportunities, aiming to improve healthcare outcomes and reduce costs. With a deep understanding of the healthcare market, Flare Capital leverages its extensive industry connections and expertise to support the growth and success of its portfolio companies.

KKR is a leading global investment firm founded in 1976, known for its pioneering role in the private equity industry. The firm is committed to delivering strong returns and shared success to its clients and the world at large. KKR invests across various asset classes, including private equity, infrastructure, real estate, and credit, with a focus on fortifying companies and communities. The firm emphasizes a culture of shared ownership and long-term value creation, aligning its interests with those of its investors and portfolio companies.

Warburg Pincus LLC is a pioneer in global growth investing, operating as a private partnership since 1966. The firm focuses on helping investors and management teams achieve enduring success across market cycles. With over $86 billion in assets under management and more than 230 companies in its active portfolio, Warburg Pincus is diversified across stages, sectors, and geographies. The firm has invested in over 1,000 companies globally across private equity, real estate, and capital solutions strategies.

Future Planet Capital is an impact-led venture capital firm based in the UK with a global reach. The firm focuses on investing in high-growth companies that address global challenges profitably, aligning with the UN Sustainable Development Goals. With over $400 million in assets under management and a portfolio of 140 companies, Future Planet Capital leverages its connections with top universities and research ecosystems to back innovative solutions in climate change, education, health, security, and sustainable growth.

Mitsui & Co. Global Investment, Inc. is a venture capital firm with over 20 years of experience, focusing on guiding entrepreneurs onto the global stage. The firm goes beyond financial support, offering strategic guidance and leveraging its vast network to facilitate key partnerships. With a commitment to improving human welfare, Mitsui partners with exceptional teams to reinvent industries worldwide.

Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm. The firm focuses on helping growing health care companies achieve their full potential while improving global health care. They manage capital in both private and public equity funds, investing across all sectors of the health care industry, including biopharmaceutical services, health care services, and medical devices. Great Point Partners is known for its proactive and proprietary approach to sourcing investments and has provided growth equity, recapitalization, and management buyout financing to more than 200 health care companies.

Escalate Capital Partners is a prominent private credit and growth equity investment firm focusing on rapidly growing later-stage companies in the technology, software, services, and healthcare sectors. With a robust investment history, the firm has deployed $1.3 billion to accelerate growth while minimizing dilution for management and equity holders. The firm prides itself on providing stable and tailored capital solutions, backed by an experienced investment team with over 100 years of combined expertise, having invested over $2 billion in more than 500 companies.

Belle Impact Fund is dedicated to investing in women-led companies, aiming to provide superior returns for its investors while addressing the early-stage capital needs of these businesses. The fund is committed to empowering women entrepreneurs and fostering innovation across various industries.

LSG Investments is an evergreen venture fund dedicated to advancing healthcare by investing in early-stage life sciences technologies. The firm focuses on strengthening Pennsylvania's life sciences ecosystem and improving global healthcare outcomes. By providing early-stage capital and operational expertise, LSG Investments fosters company growth and job creation, bridging the gap between pre-seed and Series B funding.

Mercury Fund is an early-stage venture capital platform focused on transformative software startups across America. With a mission to drive exceptional outcomes for founders and investors, Mercury Fund emphasizes supporting underrepresented entrepreneurial communities. The firm has created over $9 billion in value through its operationally-focused investment strategy, partnering with both first-time and seasoned entrepreneurs to leverage growth networks and achieve sustainable growth.

Omega Funds is a venture capital firm dedicated to investing in the future of medicine. The firm focuses on supporting exceptional founders and entrepreneurs in developing impactful products and platforms across various therapeutic areas, including oncology, immunology, rare diseases, and precision medicine. Omega Funds aims to bring science to patients by investing in innovative solutions that address significant medical needs.

MPM BioImpact is a world-leading biotechnology investment firm with over 30 years of experience in creating and investing in innovative companies. The firm focuses on delivering transformative therapies to patients by investing in both private and public biotech companies. MPM BioImpact is dedicated to impact investing, managing over $3 billion in assets across early-stage venture funds, private/public impact funds, and a public equities fund. The firm is known for its role as a company creator, leveraging deep domain expertise in research and development, clinical strategy, and commercialization to build successful biotech companies.

Sofinnova is a leading healthcare investment firm with a focus on life sciences, particularly therapeutic drugs. Founded in 1976, the firm has a strong track record of investing in transformative therapies, guiding companies from drug development through regulatory processes to IPOs. With approximately $3.3 billion in assets under management, Sofinnova partners with entrepreneurs to improve patient lives through science, leveraging deep industry knowledge and extensive experience in both private and public equity markets.

Revelation Partners is a healthcare-focused investment firm that provides liquidity and capital solutions to healthcare investors, companies, and funds. With over $1.5 billion in assets under management, the firm specializes in flexible capital solutions, shareholder liquidity, and fund manager solutions. Revelation Partners actively partners with management teams to scale rapidly growing healthcare companies and offers customized solutions to align shareholders and provide liquidity.